Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications

被引：0

作者：

Lisa Pleyer

Sonja Burgstaller

Reinhard Stauder

Michael Girschikofsky

Heinz Sill

Konstantin Schlick

Josef Thaler

Britta Halter

Sigrid Machherndl-Spandl

Armin Zebisch

Angelika Pichler

Michael Pfeilstöcker

Eva-Maria Autzinger

Alois Lang

Klaus Geissler

Daniela Voskova

Dietmar Geissler

Wolfgang R. Sperr

Sabine Hojas

Inga M. Rogulj

Johannes Andel

Richard Greil

机构：

[1] Paracelsus Medical University Salzburg,3rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center

[2] Center for Clinical Cancer and Immunology Trials at Salzburg Cancer Research Institute,Department of Internal Medicine IV

[3] Cancer Cluster Salzburg,Department of Internal Medicine V

[4] Klinikum Wels-Grieskirchen,Department of Hematology and Oncology

[5] Innsbruck Medical University,Department of Hematology

[6] Elisabethinen Hospital,Department for Hematology and Oncology

[7] Medical University of Graz,3rd Medical Department for Hematology and Oncology

[8] LKH Leoben,First Medical Department, Center for Oncology, Hematology and Palliative Care

[9] Hanusch Hospital,Department of Internal Medicine

[10] Wilhelminenspital,5th Medical Department

[11] LKH Feldkirch,Department of Internal Medicine III

[12] Hospital Hietzing,1st Medical department

[13] General Hospital,Department of Internal Medicine I, Division of Hematology and Hemostaseology

[14] Klinikum Klagenfurt,Department of Internal Medicine

[15] Medical University of Vienna,Department of Hematology

[16] LKH Fürstenfeld,Department of Internal Medicine II

[17] Clinical Hospital Merkur,undefined

[18] LKH Steyr,undefined

来源：

Journal of Hematology & Oncology | / 9卷

关键词：

AML; MDS; WHO; FAB; Classification; RAEB-t; Bone marrow blast count; Azacitidine; Austrian Azacitidine Registry;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 12 条

[1] Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications
Pleyer, Lisa
Burgstaller, Sonja
Stauder, Reinhard
Girschikofsky, Michael
Sill, Heinz
Schlick, Konstantin
Thaler, Josef
Halter, Britta
Machherndl-Spandl, Sigrid
Zebisch, Armin
Pichler, Angelika
Pfeilstoecker, Michael
Autzinger, Eva-Maria
Lang, Alois
Geissler, Klaus
Voskova, Daniela
Geissler, Dietmar
Sperr, Wolfgang R.
Hojas, Sabine
Rogulj, Inga M.
Andel, Johannes
Greil, Richard
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
[2] Myelodysplastic syndromes, from French-American-British to World Health Organization:: comparison of classifications on 431 unselected patients from a single institution
Nösslinger, T
Reisner, R
Koller, E
Grüner, H
Tüchler, H
Nowotny, H
Pittermann, E
Pfeilstöcker, M
BLOOD, 2001, 98 (10) : 2935 - 2941
[3] To the editor: Myelodysplastic syndromes: from French-American-British to World Health Organization: a commentary
Bennett, JM
Brunning, RD
Vardiman, JW
BLOOD, 2002, 99 (08) : 3074 - 3075
[4] Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes:: results of a single-center analysis
Mueller-Berndorff, H.
Haas, P. S.
Kunzmann, R.
Schulte-Moenting, J.
Luebbert, M.
ANNALS OF HEMATOLOGY, 2006, 85 (08) : 502 - 513
[5] Platelet count is an independent prognostic factor in myelodysplastic syndromes considered as low risk by French-American-British and World Health Organisation classifications
Breccia, Massimo
D'elia, Gianna Maria
Cannella, Laura
Stefanizzi, Caterina
Fama, Angelo
Federico, Vincenzo
Santopietro, Michelina
Alimena, Giuliana
LEUKEMIA & LYMPHOMA, 2009, 50 (05) : 841 - 843
[6] Comparison of five prognostic scoring systems, the French–American–British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: results of a single-center analysis
H. Müller-Berndorff
P. S. Haas
R. Kunzmann
J. Schulte-Mönting
M. Lübbert
Annals of Hematology, 2006, 85 : 502 - 513
[7] Prevalence of MDS subtypes in Shanghai, China: A comparison of the World Health Organization and French American British classifications
Irons, RD
Wang, XQ
Gross, SA
Bao, LM
Ryder, J
Chen, Y
Chen, H
Sun, HJ
Zhou, J
Ji, MR
Du, XY
Fu, H
Lin, GW
LEUKEMIA RESEARCH, 2006, 30 (07) : 769 - 775
[8] Comparison between azacitidine and decitabine as front-line therapy in elderly acute myeloid leukemia patients not eligible for intensive chemotherapy
Maurillo, L.
Spagnoli, A.
Candoni, A.
Papayannidis, C.
Borlenghi, E.
Lazzarotto, D.
Fianchi, L.
Sciume, M.
Zannier, M. E.
Buccisano, F.
Del Principe, M. I.
Mancini, V.
Breccia, M.
Fanin, R.
Todisco, E.
Lunghi, M.
Palmieri, R.
Fracchiolla, N.
Musto, P.
Rossi, G.
Venditti, A.
LEUKEMIA RESEARCH, 2023, 127
[9] Comparison of cytogenetics in patients with acute myeloid leukemia (AML): French-American-British (FAB) classification M5 versus non-M5.
Hulshizer, C
Paietta, E
Bennett, JM
Hicks, G
Cassileth, PA
Rowe, JM
Wiernik, PH
Tallman, MS
Dewald, GW
BLOOD, 2002, 100 (11) : 244B - 244B
[10] Acute myeloid leukemia-type chemotherapy for newly diagnosed patients without antecedent cytopenias having myelodysplastic syndrome as defined by French-American-British criteria: A cancer and leukemia group B study
Bernstein, SH
Brunette, VL
Davey, FR
WursterHill, D
Mayer, RJ
Stone, RM
Schiffer, CA
Bloomfield, CD
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (09) : 2486 - 2494

← 1 2 →